Learn More
Medchemexpress LLC β-nicotinamide mononucleotide, reduced form disodium | 108347-85-9 | 99.6% | 380.20 g·mol-1 | C11H15N2Na2O8P | 25 MG

Supplier: Medchemexpress LLC HYW615108B25MG
β-Nicotinamide mononucleotide, reduced form (disodium) is the reduced form of β-nicotinamide mononucleotide (NMNH), an endogenous NAD+ precursor used in biochemical and cellular research. The disodium salt is supplied as a solid and is characterized for identity and purity.
- Provides the reduced NMN (NMNH) disodium salt for NAD+ metabolism studies.
- High purity suitable for analytical and cellular applications.
- Solid form with light yellow to yellow appearance.
- Storage: -20°C for solid; in solvent: -80°C up to 6 months or -20°C up to 1 month.
- Characterized by HPLC, 1H NMR, and MS to confirm identity.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.